Table 1.
Characteristics of Participants According to Systolic Blood Pressure Time in Target Range
| TTR Group | |||||
|---|---|---|---|---|---|
| 0 to <25% (n=1742) | 25 to <50% (n=1392) | 50 to <75% (n=1585) | 75 to <100% (n=1443) | P-Value | |
| Age | 68 (10) | 69 (10) | 68 (9) | 67 (9) | <.001 |
| Female | 701 (40%) | 558 (40%) | 591 (37%) | 469 (33%) | <.001 |
| White | 968 (56%) | 829 (60%) | 915 (58%) | 825 (57%) | .028 |
| Black | 559 (32%) | 413 (30%) | 446 (28%) | 419 (29%) | |
| Clinical Cardiovascular Disease | 287 (17%) | 262 (19%) | 257 (16%) | 221 (15%) | .08 |
| 10-Year ASCVD Risk | 23 (12) | 22 (12) | 22 (11) | 20 (11) | <.001 |
| Baseline SBP | 149 (17) | 147 (16) | 145 (15) | 139 (12) | <.001 |
| Number of BP Lowering Agents | .15 | ||||
| 0 | 193 (11%) | 133 (10%) | 177 (11%) | 155 (11%) | |
| 1 | 458 (26%) | 425 (31%) | 482 (30%) | 438 (30%) | |
| 2 | 598 (34%) | 460 (33%) | 526 (33%) | 502 (35%) | |
| 3 or more | 493 (28%) | 374 (27%) | 400 (25%) | 348 (24%) | |
| Statin | 660 (38%) | 589 (43%) | 679 (43%) | 634 (44%) | <.002 |
| Time in Target Range | 8 (9) | 38 (7) | 62 (8) | 86 (8) | <.001 |
| Mean SBP | 140 (15) | 130 (10) | 126 (8) | 124 (7) | <.001 |
| SBP Standard Deviation | 10 (7) | 14 (6) | 12 (5) | 9 (4) | <.001 |